Item 9 Labs Corp (INLB)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 17, 15:34
Item 9 Labs Revenue (Quarterly): 5.022M for June 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 5.022M |
| March 31, 2023 | 5.663M |
| December 31, 2022 | 5.004M |
| September 30, 2022 | 4.002M |
| June 30, 2022 | 4.931M |
| March 31, 2022 | 6.638M |
| December 31, 2021 | 6.186M |
| September 30, 2021 | 6.094M |
| June 30, 2021 | 6.693M |
| March 31, 2021 | 6.111M |
| December 31, 2020 | 3.040M |
| September 30, 2020 | 2.519M |
| June 30, 2020 | 2.208M |
| March 31, 2020 | 1.862M |
| December 31, 2019 | 1.533M |
| September 30, 2019 | 1.306M |
| June 30, 2019 | 1.542M |
| March 31, 2019 | 1.130M |
| December 31, 2018 | 0.9556M |
| September 30, 2018 | 0.4297M |
| June 30, 2018 | 0.4399M |
| March 31, 2018 | 0.2814M |
| December 31, 2017 | 0.0996M |
| September 30, 2017 | 0.0667M |
| June 30, 2017 | 0.1286M |
| Date | Value |
|---|---|
| March 31, 2017 | 0.0381M |
| December 31, 2016 | 0.0106M |
| September 30, 2016 | 0.1417M |
| June 30, 2016 | 0.0645M |
| March 31, 2016 | 0.013M |
| December 31, 2015 | 0.1049M |
| September 30, 2015 | -0.0049M |
| June 30, 2015 | 0.0141M |
| March 31, 2015 | 0.0105M |
| December 31, 2014 | 0.0933M |
| September 30, 2014 | 0.0108M |
| June 30, 2014 | 0.1134M |
| March 31, 2014 | 0.0446M |
| December 31, 2013 | 0.0107M |
| September 30, 2013 | 0.1425M |
| June 30, 2013 | 0.0007M |
| March 31, 2013 | 0.1196M |
| December 31, 2012 | 0.0792M |
| June 30, 2012 | 0.0009M |
| March 31, 2012 | 0.0138M |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | 0.0601M |
| March 31, 2011 | 0.0227M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.306M
Minimum
Sep 2019
6.693M
Maximum
Jun 2021
4.138M
Average
4.931M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Humanigen Inc | 0.221M |
| Cannabis Global Inc | 0.7924M |
| Cantabio Pharmaceuticals Inc | -- |
| Affymax Inc | -- |
| Statera BioPharma Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.911M |
| Total Expenses (Quarterly) | 7.820M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 56.13% |
| Profit Margin (Quarterly) | -117.7% |